Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Devost

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Molecular Endocrinology (Baltimore, Md.)|March 20, 2004
Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and meninAnnie Lacerte, Eun-Hye Lee, Rachel Reynaud, et al.
The Journal of Biological Chemistry|December 17, 2014
Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cellsEugénie Goupil, Dany Fillion, Stéphanie Clément, et al.
Cellular Signalling|February 26, 2022
IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammationVirginie Mercier, Gabrielle Boucher, Dominic Devost, et al.
Neuropharmacology|August 10, 2015
Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptorsAnne-Julie Chabot-Doré, Magali Millecamps, Lina Naso, et al.
Biochemical Pharmacology|October 23, 2018
BRET-based assay to monitor EGFR transactivation by the AT<sub>1</sub>R reveals G<sub>q/11</sub> protein-independent activation and AT<sub>1</sub>R-EGFR complexesShannon L O'Brien, Elizabeth K M Johnstone, Dominic Devost, et al.
Biochemical Pharmacology|September 11, 2021
Corrigendum to "BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes" [Biochem. Pharmacol. 158 (2108) 232-242]Shannon L O'Brien, Elizabeth K M Johnstone, Dominic Devost, et al.
The Journal of Biological Chemistry|June 17, 2010
A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathwayEugénie Goupil, Danaë Tassy, Carine Bourguet, et al.
Elife|December 23, 2021
Addition of a carboxy-terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female miceChirine Toufaily, Jérôme Fortin, Carlos Ai Alonso, et al.
Science Signaling|December 6, 2018
Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensorsYoon Namkung, Christian LeGouill, Sahil Kumar, et al.
Scientific Reports|May 31, 2020
Signal profiling of the β<sub>1</sub>AR reveals coupling to novel signalling pathways and distinct phenotypic responses mediated by β<sub>1</sub>AR and β<sub>2</sub>ARViktoriya Lukasheva, Dominic Devost, Christian Le Gouill, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Endocrinology (Baltimore, Md.)|March 20, 2004
Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and meninAnnie Lacerte, Eun-Hye Lee, Rachel Reynaud, et al.
The Journal of Biological Chemistry|December 17, 2014
Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cellsEugénie Goupil, Dany Fillion, Stéphanie Clément, et al.
Cellular Signalling|February 26, 2022
IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammationVirginie Mercier, Gabrielle Boucher, Dominic Devost, et al.
Neuropharmacology|August 10, 2015
Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptorsAnne-Julie Chabot-Doré, Magali Millecamps, Lina Naso, et al.
Biochemical Pharmacology|October 23, 2018
BRET-based assay to monitor EGFR transactivation by the AT<sub>1</sub>R reveals G<sub>q/11</sub> protein-independent activation and AT<sub>1</sub>R-EGFR complexesShannon L O'Brien, Elizabeth K M Johnstone, Dominic Devost, et al.
Biochemical Pharmacology|September 11, 2021
Corrigendum to "BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes" [Biochem. Pharmacol. 158 (2108) 232-242]Shannon L O'Brien, Elizabeth K M Johnstone, Dominic Devost, et al.
The Journal of Biological Chemistry|June 17, 2010
A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathwayEugénie Goupil, Danaë Tassy, Carine Bourguet, et al.
Elife|December 23, 2021
Addition of a carboxy-terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female miceChirine Toufaily, Jérôme Fortin, Carlos Ai Alonso, et al.
Science Signaling|December 6, 2018
Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensorsYoon Namkung, Christian LeGouill, Sahil Kumar, et al.
Scientific Reports|May 31, 2020
Signal profiling of the β<sub>1</sub>AR reveals coupling to novel signalling pathways and distinct phenotypic responses mediated by β<sub>1</sub>AR and β<sub>2</sub>ARViktoriya Lukasheva, Dominic Devost, Christian Le Gouill, et al.
Pageof 5